Smilow Cancer Hospital of Yale New Haven

New Haven, Connecticut 06520

Use our guide to learn which trials are right for you!

We've found
17 trials
at this facility
Endometrial Cancer Clinical Trial
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Status: Enrolling, Phase II
Updated: 8/20/2015
mi
from
New Haven, CT
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)
Status: Enrolling, Phase I, II
Updated: 3/21/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC Clinical Trial
A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations
Status: Enrolling, Phase I, II
Updated: 4/1/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Metastatic Colorectal Cancer Clinical Trial
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Status: Enrolling, Phase II
Updated: 10/30/2014
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10
Status: Enrolling, Phase I
Updated: 8/28/2015
mi
from
New Haven, CT
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype
Status: Enrolling, Phase I
Updated: 2/16/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Nonsquamous Nonsmall Cell Neoplasm of Lung Clinical Trial
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 2/25/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Status: Enrolling, Phase III
Updated: 3/28/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Pancreatic Neoplasms Clinical Trial
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Status: Enrolling, Phase II
Updated: 3/30/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 5/31/2012
mi
from
New Haven, CT
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Lymph Node Mapping in Patients With Endometrial Cancer
Status: Enrolling
Updated: 2/8/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
Status: Enrolling, Phase III
Updated: 10/30/2015
mi
from
New Haven, CT
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Efficacy Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer
Status: Enrolling, Phase III
Updated: 3/28/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)
Status: Enrolling, Phase I
Updated: 2/6/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Status: Enrolling, Phase III
Updated: 2/4/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Status: Enrolling, Phase II
Updated: 2/5/2016
mi
from
New Haven, CT
Click here to add this to my saved trials